Clinical Trial Update: Florbetaben for Imaging of Vascular Amyloid

View source ↗

Summary

A clinical trial is recruiting to evaluate Florbetaben for imaging vascular amyloid, sponsored by the Ottawa Heart Institute Research Corporation, focusing on a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Syndrome
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• florbetaben (florbetaben)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Acute Coronary Syndrome, Stroke | Status: RECRUITING